MedPath

Assessment of a Mobile Intervention to Increase Adherence to Asthma Medication Among Adolescents

Not Applicable
Withdrawn
Conditions
Asthma
Interventions
Device: Inhaler sensor
Behavioral: Mobile application for asthma adherence
Registration Number
NCT02426814
Lead Sponsor
CoheroHealth
Brief Summary

The purpose of this study is to assess the use of a mobile health intervention to improve adherence to asthma medication among adolescents. The intervention consists of an inhaler sensor strap to monitor asthma inhaler use and a mobile phone application to remind and incentivize patients to use their medication. This study will assess medication use throughout a 12 week study in patients who receive a mobile app with reminders, asthma control as measured by the ACT \[asthma control test\], and lung function as measured by spirometry.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age 11-19
  • Asthma diagnosis
  • Currently prescribed a hydrofluoroalkane (HFA) asthma controller medication
  • English-speaking
  • Has a smartphone or access to a smartphone or tablet
Exclusion Criteria
  • Pregnant
  • Foster Care
  • Emancipated minor

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Medication Monitoring and Mobile AppInhaler sensorPatients will be given an inhaler sensor to monitor medication use and a mobile phone application with reminders to allow self-management of medication use. Interventions: inhaler sensor and mobile application for asthma adherence
Medication Monitoring and Mobile AppMobile application for asthma adherencePatients will be given an inhaler sensor to monitor medication use and a mobile phone application with reminders to allow self-management of medication use. Interventions: inhaler sensor and mobile application for asthma adherence
Standard Care with Medication MonitoringInhaler sensorPatients will be given an inhaler sensor to monitor medication use and a sham version of the mobile app that will not include reminders or incentives. Intervention: inhaler sensor
Primary Outcome Measures
NameTimeMethod
Real-time medication adherence in patients using mobile app compared to standard care.12 weeks

Analysis of real-time medication use data in the experimental \[app + sensor\] arm vs the sensor only arm.

Secondary Outcome Measures
NameTimeMethod
Asthma control in patients using mobile app compared to standard care12 weeks

Analysis of the ACT \[asthma control test\] at baseline and follow up for patients in each arm to assess changes in asthma control with use of the mobile app.

Change in lung function with use of a mobile health tool for asthma adherence12 weeks

Measure change in spirometry by comparing force expiratory volume at one second \[FEV1\] and forced vital capacity \[FVC\] at baseline and 12 week visit.

Trial Locations

Locations (1)

Mount Sinai Hospital

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath